<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Live Business News &#187; Pharmaceuticals</title>
	<atom:link href="http://www.livebiznews.com/category/fortune-global-companies/pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.livebiznews.com</link>
	<description>A Leading Market Information Resource</description>
	<lastBuildDate>Sun, 14 Apr 2013 07:19:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
		<item>
		<title>Wyeth &#8211; Latest Company News</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:54:43 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[adverse drug reactions]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[david archer]]></category>
		<category><![CDATA[fda submissions]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[osteoporotic fractures]]></category>
		<category><![CDATA[prevention of osteoporosis]]></category>
		<category><![CDATA[treatment of osteoporosis]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1990</guid>
		<description><![CDATA[Ligand receives $250,000 from Wyeth 17 Oct 2007 The payment arises from an agreement between the two companies and reflects progress in the development of bazedoxifene, a selective estrogen receptor modulator. Bazedoxifene is a synthetic drug that was designed to reduce the risk of osteoporotic fractures while protecting breast and uterine tissues. Wyeth received an]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Latest Company Comment</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:52:30 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[acute gastroenteritis]]></category>
		<category><![CDATA[dose regimen]]></category>
		<category><![CDATA[gastroenteritis in infants]]></category>
		<category><![CDATA[human rotavirus]]></category>
		<category><![CDATA[immunization schedules]]></category>
		<category><![CDATA[live attenuated vaccine]]></category>
		<category><![CDATA[national immunization]]></category>
		<category><![CDATA[rotarix]]></category>
		<category><![CDATA[rotavirus vaccine]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1987</guid>
		<description><![CDATA[GlaxoSmithKline: progress for Rotarix in key US market 15 Aug 2007 GlaxoSmithKline&#8217;s rotavirus vaccine has been accepted for review by the FDA. The FDA has accepted GSK&#8217;s application for Rotarix for review. Rotarix, a live attenuated vaccine derived from the most common human rotavirus strain, is used in infants to prevent rotavirus gastroenteritis. Rotavirus infects]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Locations and Subsidiaries</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:47:36 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[giralda farms]]></category>
		<category><![CDATA[john wyeth]]></category>
		<category><![CDATA[laboratorios wyeth]]></category>
		<category><![CDATA[Locations]]></category>
		<category><![CDATA[rua alexandre dumas]]></category>
		<category><![CDATA[wyeth australia]]></category>
		<category><![CDATA[wyeth india]]></category>
		<category><![CDATA[wyeth pharma]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1985</guid>
		<description><![CDATA[Head Office Wyeth 5 Giralda Farms Madison New Jersey 07940 USA P:1 973 660 5000 www.wyeth.com Other Locations and Subsidiaries Wyeth Pharmaceuticals (Canada) 50 Minthorn Boulevard Markham Ontario L3T 7Y2 CAN Wyeth (Mexico) Avenida 1 de Mayo No 127 Col San Andres Atoto Naucalpan Edo de Mexico MEX Laboratorios Wyeth-Whitehall Rua Alexandre Dumas 2200 5th]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Top Competitors</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:38:47 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[bristol myers squibb]]></category>
		<category><![CDATA[bristol myers squibb company]]></category>
		<category><![CDATA[Competitors]]></category>
		<category><![CDATA[merck co inc]]></category>
		<category><![CDATA[myers squibb company]]></category>
		<category><![CDATA[novadel pharma]]></category>
		<category><![CDATA[procter gamble company]]></category>
		<category><![CDATA[roche holding ag]]></category>
		<category><![CDATA[sanofi aventis]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1980</guid>
		<description><![CDATA[The following companies are the major competitors of Wyeth: AstraZeneca PLC Sanofi-Aventis Group Bayer AG Bristol-Myers Squibb Company Eli Lilly and Company Johnson &#38; Johnson Merck &#38; Co., Inc. Novartis AG Pfizer Inc Roche Holding AG GlaxoSmithKline Plc Procter &#38; Gamble Company, The Millennium Pharmaceuticals Barr Pharmaceuticals Novo Nordisk A/S NovaDel Pharma Inc]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Major Products and Services</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:31:32 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[allergy remedies]]></category>
		<category><![CDATA[benefix]]></category>
		<category><![CDATA[growth implants]]></category>
		<category><![CDATA[immunological products]]></category>
		<category><![CDATA[parasite control]]></category>
		<category><![CDATA[Products and Services]]></category>
		<category><![CDATA[refacto]]></category>
		<category><![CDATA[tazocin]]></category>
		<category><![CDATA[zosyn]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1978</guid>
		<description><![CDATA[Wyeth is a research-based pharmaceutical and health care products company. The company&#8217;s products and services are categorized under the following different segments: Pharmaceuticals: Neuroscience therapies Cardiovascular products Nutritionals Gastroenterology drugs Anti-infectives Vaccines Oncology therapies Musculoskeletal therapies Hemophilia treatments Immunological products Women&#8217;s healthcare products Consumer healthcare: Analgesics Cough/cold/allergy remedies Nutritional supplements Hemorrhoidal treatments Asthma and personal-care]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Company View</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 19:13:01 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Centrum]]></category>
		<category><![CDATA[challenge]]></category>
		<category><![CDATA[Company View]]></category>
		<category><![CDATA[Consumer]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[reformulation]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1982</guid>
		<description><![CDATA[A statement by Robert Essner, Chairman and Chief Executive Officer of Wyeth is given below. The statement has been taken from the company’s annual report 2006. I am pleased to report that 2006 was an excellent year for Wyeth. Building on our strong performance in 2005, we once again delivered on our commitment to expand]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Key Facts</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:52:52 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[buenos aires]]></category>
		<category><![CDATA[fax web]]></category>
		<category><![CDATA[giralda farms]]></category>
		<category><![CDATA[Key Facts]]></category>
		<category><![CDATA[madison new jersey]]></category>
		<category><![CDATA[mexico city]]></category>
		<category><![CDATA[usa phone]]></category>
		<category><![CDATA[wye wyeth]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1925</guid>
		<description><![CDATA[Head Office Wyeth 5 Giralda Farms Madison New Jersey 07940 USA Phone 1 973 660 5000 Fax Web Address www.wyeth.com Revenue / turnover (USD Mn) 20,350.7 Financial Year End December Employees 50,060 New York Ticker WYE Buenos Aires Ticker WYE Mexico City Stock Exchange Ticker WYE]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Business Description</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:51:24 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Business Description]]></category>
		<category><![CDATA[effexor xr]]></category>
		<category><![CDATA[ethical pharmaceuticals]]></category>
		<category><![CDATA[healthcare institutions]]></category>
		<category><![CDATA[healthcare segment]]></category>
		<category><![CDATA[hemophilia treatments]]></category>
		<category><![CDATA[immunological products]]></category>
		<category><![CDATA[wyeth consumer healthcare]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1927</guid>
		<description><![CDATA[Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of health care products. The company sells its line of products to wholesalers, pharmacies, hospitals, physicians, retailers and other healthcare institutions located in various markets in more than 145 countries. The company has three primary business segments: pharmaceuticals, consumer healthcare]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; History</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:48:04 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[animal health division]]></category>
		<category><![CDATA[animal health products]]></category>
		<category><![CDATA[conjugate vaccine]]></category>
		<category><![CDATA[diphtheria crm197 protein]]></category>
		<category><![CDATA[History]]></category>
		<category><![CDATA[human pharmaceuticals]]></category>
		<category><![CDATA[invasive pneumococcal disease]]></category>
		<category><![CDATA[john wyeth]]></category>
		<category><![CDATA[sherwood medical]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1930</guid>
		<description><![CDATA[Wyeth was founded in the 1860s as a small drugstore called John Wyeth and Brother. In 1931, American Home Products (AHP) purchased Wyeth from Harvard University, which had acquired a controlling interest in the firm from John Wyeth’s son and heir. Growth was fairly rapid and the company began to expand internationally. By 1944, the]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Key Employees</title>
		<link>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/</link>
		<comments>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:44:34 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[chief information officer]]></category>
		<category><![CDATA[corporate business development]]></category>
		<category><![CDATA[corporate information services]]></category>
		<category><![CDATA[ivan g seidenberg]]></category>
		<category><![CDATA[john d feerick]]></category>
		<category><![CDATA[Key Employees]]></category>
		<category><![CDATA[robert essner]]></category>
		<category><![CDATA[robert langer]]></category>
		<category><![CDATA[vice president human resources]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1932</guid>
		<description><![CDATA[Name Job Title Board Robert Essner Chairman and Chief Executive Officer Executive Board Bernard Poussot Vice Chairman, President and Chief Operating Officer Executive Board John D Feerick Director Non Executive Board Frances D Fergusson Director Non Executive Board Victor F Ganzi Director Non Executive Board Robert Langer Director Non Executive Board John P Mascotte Director]]></description>
		<wfw:commentRss>http://www.livebiznews.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
